Justyna Paleczny
Overview
Explore the profile of Justyna Paleczny including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
231
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brozyna M, Dudek B, Kozlowska W, Malec K, Paleczny J, Detyna J, et al.
Sci Rep
. 2024 Jan;
14(1):2218.
PMID: 38278929
Essential Oils (EOs) are currently being researched as potential antibiofilm agents to combat infections related to chronic wound biofilms. As documented in the literature, EOs' in vitro antibacterial properties are...
2.
Paleczny J, Brozyna M, Dudek B, Woyton A, Chodaczek G, Szajnik M, et al.
Int J Mol Sci
. 2023 Dec;
24(24).
PMID: 38139071
Credible assessment methods must be applied to evaluate antiseptics' in vitro activity reliably. Studies indicate that the medium for biofilm culturing should resemble the conditions present at the site of...
3.
Paleczny J, Junka A, Krzyzek P, Czajkowska J, Kramer A, Benkhai H, et al.
Front Cell Infect Microbiol
. 2023 Apr;
13:1119188.
PMID: 37009512
Chronic wound infection is highly associated with morbidity and endangers the patient's life. Therefore, wound care products must have a potent antimicrobial and biofilm-eradicating effect. In this work, the antimicrobial/antibiofilm...
4.
Krasowski G, Migdal P, Woroszylo M, Fijalkowski K, Chodaczek G, Czajkowska J, et al.
Int J Mol Sci
. 2022 Nov;
23(21).
PMID: 36362310
Staphylococcal biofilms are major causative factors of non-healing wound infections. Their treatment algorithms recommend the use of locally applied antiseptic agents to counteract the spread of infection. The efficacy of...
5.
Dziedzic E, Tuzimek A, Gasior J, Paleczny J, Junka A, Kwasny M, et al.
Nutrients
. 2022 Oct;
14(19).
PMID: 36235759
The prevalence of coronary artery disease (CAD) increases every year; however, the impact of microelements on its underlying cause-atherosclerosis-is still unclear. Copper plays numerous regulatory roles in cardiovascular health and...
6.
Paleczny J, Brozyna M, Dudek-Wicher R, Dydak K, Oleksy-Wawrzyniak M, Madziala M, et al.
Int J Mol Sci
. 2022 Oct;
23(19).
PMID: 36232864
The biofilm-associated infections of bones are life-threatening diseases, requiring application of dedicated antibiotics in order to counteract the tissue damage and spread of microorganisms. The in vitro analyses on biofilm...
7.
Dziedzic E, Gasior J, Tuzimek A, Paleczny J, Junka A, Dabrowski M, et al.
Int J Mol Sci
. 2022 Sep;
23(17).
PMID: 36076952
Atherosclerosis, the underlying cause of coronary artery disease (CAD), has a significant inflammatory component. White blood cell count is an affordable and accessible way to assess the systemic immune response,...
8.
Dziedzic E, Gasior J, Tuzimek A, Paleczny J, Kwasny M, Dabrowski M, et al.
Biomolecules
. 2022 Jul;
12(7).
PMID: 35883417
Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Although zinc (Zn) was reported to have antioxidant, anti-inflammatory and protective properties in CVDs, its association with coronary artery disease...
9.
Brozyna M, Paleczny J, Kozlowska W, Ciecholewska-Jusko D, Parfienczyk A, Chodaczek G, et al.
Molecules
. 2022 Jul;
27(13).
PMID: 35807343
is an opportunistic pathogen causing life-threatening, hard-to-heal infections associated with the presence of a biofilm. Essential oils (EOs) are promising agents to combat pseudomonal infections because of the alleged antimicrobial...
10.
Dydak K, Junka A, Nowacki G, Paleczny J, Szymczyk-Ziolkowska P, Gorzynska A, et al.
Int J Mol Sci
. 2022 May;
23(9).
PMID: 35563224
Hernia repairs are the most common abdominal wall elective procedures performed by general surgeons. Hernia-related postoperative infective complications occur with 10% frequency. To counteract the risk of infection emergence, the...